alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Clinical trials

Clinical trials

Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.

If you are thinking about joining a trial

A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.

Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.

Clear filters Download all 7,816 as CSV

"Open to new participants" means the registry status is RECRUITING or NOT_YET_RECRUITING — 1,523 of the 7,816 records. That is what the sponsor last told the registry, which can be months out of date.
Location is by country. This pull of the registry records the countries a study runs in, not its individual sites, so we cannot filter by US state or city — and we are not going to guess one. To find the nearest site, open a trial's record below: the official page lists every location with its contact details.

Showing 7,576–7,600 of 7,816 matching trials · page 304 of 313, 25 per page.

Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.

Registered Alzheimer's clinical trials. Every ID links to its official ClinicalTrials.gov record.
Trial Phase Status Enrolled Sponsor Last updated
Randomized Safety, Tolerability and Pilot Efficacy of AN-1792 in Alzheimer's Disease
NCT00021723
AN-1792 also known as AIP-001
Runs in: United States · 11 sites 		PHASE2
other		 TERMINATED 375 JANSSEN Alzheimer Immunotherapy Research & Development, LLC
INDUSTRY		 2009-09-24
Pioglitazone in Alzheimer Disease
NCT00982202
pioglitazone; Placebo
Runs in: United States · 2 sites 		PHASE2
other		 COMPLETED 25 National Institute on Aging (NIA)
NIH		 2009-09-23
Cognitive and Emotional Impairment After Stroke
NCT00506818
Multifactorial vascular-risk-factor-intervention
Runs in: Norway · 1 site 		NA
other		 COMPLETED 250 Sykehuset Asker og Baerum
OTHER		 2009-09-21
A Study to Determine the Clinical Safety/Tolerability and Exploratory Efficacy of EHT 0202 as Adjunctive Therapy to Acetylcholinesterase Inhibitor in Mild to Moderate Alzheimer's Disease
NCT00880412
EHT 0202 etazolate; Placebo
Runs in: France · 22 sites 		PHASE2
symptomatic-cholinergic		 COMPLETED 197 Exonhit
INDUSTRY		 2009-09-21
Biomarkers and Early Alzheimer's Disease
NCT00094952
Runs in: United States · 1 site 		NA
other		 UNKNOWN 80 National Institute on Aging (NIA)
NIH		 2009-09-18
Passport to Brain Wellness in Sedentary Adults
NCT00979446
Guided; Self-directed
Runs in: United States · 1 site 		NA
other		 COMPLETED 63 HealthPartners Institute
OTHER		 2009-09-18
Study Evaluating SRA-333 in Mild to Moderate Alzheimer's Disease (AD)
NCT00151333
SRA-333
Runs in: United States · 3 sites 		PHASE2
other		 COMPLETED 16 Wyeth is now a wholly owned subsidiary of Pfizer
INDUSTRY		 2009-09-04
Study Evaluating How Quickly And To What Extent The 14-Carbon-SAM-531 Is Absorbed/Converted/Eliminated In Male Subjects
NCT00906191
SAM-531
Runs in: Netherlands · 1 site 		PHASE1
other		 COMPLETED 6 Wyeth is now a wholly owned subsidiary of Pfizer
INDUSTRY		 2009-08-26
Magnetic Resonance Imaging (MRI) of Brain Iron in Neurodegenerative Disease
NCT00249080 		NA
other		 COMPLETED 182 Albany Medical College
OTHER		 2009-08-24
Safety and Effect on Memory of PYM50028 in Mild Alzheimer's Disease
NCT00130429
PYM50028
Runs in: United Kingdom · 1 site 		PHASE2
other		 COMPLETED 250 Phytopharm
INDUSTRY		 2009-08-21
Evaluation of [123I] MNI-308 and SPECT as a Marker of Beta-amyloid Protein Deposition in AD Subjects Compared to HC
NCT00544453
[123I] MNI-308
Runs in: United States · 1 site 		PHASE1
other		 TERMINATED 2 Molecular NeuroImaging
OTHER		 2009-08-21
A Safety and Tolerability Evaluation of Two 10-Week Dose Regimens of Orally-Administered PF-04494700 in Alzheimer's Patients
NCT00141661
PF-04494700 - Low Dose Arm; PF-04494700 - High Dose Arm; Placebo Comparator
Runs in: United States · 12 sites 		PHASE2
other		 COMPLETED 67 Pfizer
INDUSTRY		 2009-08-20
Far Infrared Radiation Treatment of Dementia and Other Mental Illness
NCT00574054
Far Infrared
Runs in: Canada · 1 site 		PHASE1
other		 UNKNOWN 4 GAAD Medical Research Institute Inc.
OTHER		 2009-08-17
Far Infrared Treatment for Alzheimer's Disease
NCT00599469
Far Infrared Radiation (5μm to 20μm wavelength)
Runs in: Canada · 1 site 		PHASE1
other		 UNKNOWN 4 GAAD Medical Research Institute Inc.
OTHER		 2009-08-17
Far Infrared Irradiation for Control, Management and Treatment of Amyotrophic Lateral Sclerosis (ALS)
NCT00673140
Far Infrared Radiation (5μm to 20μm wavelength); Far infrared radiation
Runs in: Canada · 1 site 		PHASE1
other		 UNKNOWN 7 GAAD Medical Research Institute Inc.
OTHER		 2009-08-17
Far Infrared Irradiation for the Management, Control and Treatment of Frontotemporal Dementia
NCT00674960
Radiation: Far Infrared Radiation (5μm to 20μm wavelength)
Runs in: Canada · 1 site 		PHASE1
other		 UNKNOWN 0 GAAD Medical Research Institute Inc.
OTHER		 2009-08-17
Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SAM-531 in Healthy Japanese Males
NCT00479297
SAM-531 		PHASE1
other		 COMPLETED 72 Wyeth is now a wholly owned subsidiary of Pfizer
INDUSTRY		 2009-08-07
Study Evaluating PAZ-417 in Cerebrospinal Fluid in Subjects With Alzheimer's Disease
NCT00739037
Placebo; PAZ-417
Runs in: United States · 1 site 		PHASE1
other		 TERMINATED 10 Wyeth is now a wholly owned subsidiary of Pfizer
INDUSTRY		 2009-08-04
A Study of PRX-03140 in Subjects With Alzheimer's Disease Receiving a Stable Dose of Donepezil
NCT00672945
PRX-03140; Placebo
Runs in: United States · 38 sites 		PHASE2
symptomatic-cholinergic		 TERMINATED 420 Epix Pharmaceuticals, Inc.
INDUSTRY		 2009-07-30
Study of PRX-03140 Monotherapy in Subjects With Alzheimer's Disease
NCT00693004
PRX-03140; Donepezil; Placebo
Runs in: United States · 33 sites 		PHASE2
symptomatic-cholinergic		 TERMINATED 236 Epix Pharmaceuticals, Inc.
INDUSTRY		 2009-07-30
Study Evaluating Safety, Tolerability and Pharmacokinetics of Single and Multiple Dose of SAM-531
NCT00726115
SAM-531; placebo
Runs in: France · 1 site 		PHASE1
other		 COMPLETED 56 Wyeth is now a wholly owned subsidiary of Pfizer
INDUSTRY		 2009-07-30
Cholesterol Lowering Agent to Slow Progression (CLASP) of Alzheimer's Disease Study
NCT00053599
Simvastatin
Runs in: United States · 44 sites 		PHASE3
other		 COMPLETED 400 National Institute on Aging (NIA)
NIH		 2009-07-28
Single Dose Escalation Study of PF-04360365 In Subjects With Mild To Moderate Alzheimer's Disease
NCT00733642
PF-04360365 1 mg/kg; PF-04360365 3 mg/kg; PF-04360365 5 mg/kg; PF-0...
Runs in: United States · 3 sites 		PHASE1
other		 COMPLETED 15 Pfizer
INDUSTRY		 2009-07-28
Risk Evaluation and Education for Alzheimer's Disease (REVEAL) II
NCT00089882
APOE Genetic susceptibility testing
Runs in: United States · 4 sites 		NA
other		 COMPLETED 360 National Institute on Aging (NIA)
NIH		 2009-07-23
Risk Evaluation and Education for Alzheimer's Disease
NCT00571025
APOE Disclosure
Runs in: United States · 3 sites 		NA
other		 COMPLETED 301 National Human Genome Research Institute (NHGRI)
NIH		 2009-07-23

This table is wider than a phone screen — swipe it sideways to see the rest.

Where these trials come from

Registry
ClinicalTrials.gov, pulled through their public API (v2)
Trials in the file
7,816
Source file
trials.csv (3.8 MB, 7816 rows)
Basis
Measured These are registry records as submitted by each study's sponsor.

What could make this misleading

Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.

Always check the official record before acting on anything here. This is a summary, not medical advice.

Related evidence Treatments → What the drugs that finished their trials actually achieved.

From the research library

The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.

Clinical trials

All 162 studies on Clinical trials →